Table 2.
MRI sequences applied in the differentiation of Active Staging of TAO.
| Active Staging | MRI Sequence | MRI parameter | Research findings |
|---|---|---|---|
| Active phase | T2WI/Dixon | SIR | A cut-off SIR value of > 2.9 in the inferior rectus could be applied to evaluate the active stage of TAO{Ge, 2021 #12}. |
| T2 Mapping | T2RT | T2RTmean ≧ 74.295 could be a diagnostic cut-off for judging TAO activity{Li, 2023 #6}. | |
| DWI | ADC | The cutoff value of pretreatment n-ADC was 1.780 to detect stages{Liu, 2021 #14}. | |
| Inactive phase | T1 Mapping | T1RT/ECV | ECV>48.1% can be used as the critical value for screening inactive TAO{Ma, 2022 #15}. |
| MTI | MTR | Patients with active TAO showed significantly lower MTRs than those with inactive TAO{Hu, 2022 #16}. |
T2WI, T2-weighted images; DWI, diffusion-weighted imaging; MTI, Magnetization transfer imaging; SIR, signal intensity ratio; T2RT, T2 relaxation time; ADC, apparent diffusion coefficient; T1RT, T1 relaxation time; ECV, extracellular-volume; MTR, magnetization transfer ratio; TAO, thyroid associated ophthalmopathy.